晚期胎儿生长受限诊断标准差异是否重要
基于TRUFFLE 2可行性研究856例单胎妊娠32+0至36+6周有胎儿生长受限风险的孕妇,选取564例有孕中期生物测量数据者,比较Delphi共识与母胎医学会定义结合不同生物测量标准和多普勒参考范围对胎儿生长受限诊断比例及结局识别的影响。不同组合诊断比例从38%到93%不等,Delphi共识定义结合Arduini多普勒参考范围与不良围产结局显著相关,而母胎医学会定义未能准确识别不良围产结局。
要点
- 不同定义、生物测量标准与多普勒参考范围组合诊断胎儿生长受限比例从38%到93%不等。
- Delphi共识定义结合Arduini多普勒参考范围与不良围产结局显著相关。
- 母胎医学会定义无论用何种估计胎儿体重标准均未能准确识别不良围产结局。
核心结论
- 不同胎儿生长受限定义、生物测量标准与多普勒参考范围组合识别出不同比例的胎儿生长受限胎儿,不良围产结局差异可能不大,但对干预率可能有显著影响。
研究设计与样本
- 来自TRUFFLE 2可行性研究,856例单胎妊娠32+0至36+6周有胎儿生长受限风险的孕妇中选取564例有孕中期生物测量数据者进行比较。
- 使用Hadlock、INTERGROWTH-21st和GROW及Chitty的估计胎儿体重和腹围标准/图表。
- 脐动脉搏动指数及其与大脑中动脉搏动指数比值的百分位使用Arduini和Ebbing参考图表计算。
- 评估低出生体重和不良围产结局的敏感度和特异度。
主要发现
- 不同定义与参考图表组合诊断胎儿生长受限比例从38%(Delphi共识定义、INTERGROWTH-21st生物测量标准、Arduini多普勒参考范围)到93%(母胎医学会定义、Hadlock生物测量标准)不等。
- 所有组合对出生体重<第10百分位的相对风险在1.4到2.1之间。
- 出生体重<第10百分位在GROW/Chitty图表选择时最常出现,Hadlock标准稍少,INTERGROWTH-21st标准最少。
- 使用Ebbing多普勒参考范围识别为胎儿生长受限的比例远高于Arduini多普勒参考范围,Delphi共识定义结合Ebbing多普勒参考范围的结果与母胎医学会定义相似。
- Delphi共识定义结合Arduini多普勒参考范围与不良围产结局显著相关,无论使用何种生物测量标准/图表;母胎医学会定义无论用何种估计胎儿体重标准/图表均未能准确检测不良围产结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Criteria for diagnosis of fetal growth restriction differ widely according to national and international guidelines, and further heterogeneity arises from the use of different biometric and Doppler reference charts, making the diagnosis of fetal growth restriction highly variable. OBJECTIVE: This study aimed to compare fetal growth restriction definitions between Delphi consensus and Society for Maternal-Fetal Medicine definitions, using different standards/charts for fetal biometry and different reference ranges for Doppler velocimetry parameters. STUDY DESIGN: From the TRUFFLE 2 feasibility study (856 women with singleton pregnancy at 32+0 to 36+6 weeks of gestation and at risk of fetal growth restriction), we selected 564 women with available mid-pregnancy biometry. For the comparison, we used standards/charts for estimated fetal weight and abdominal circumference from Hadlock, INTERGROWTH-21st, and GROW and Chitty. Percentiles for umbilical artery pulsatility index and its ratios with middle cerebral artery pulsatility index were calculated using Arduini and Ebbing reference charts. Sensitivity and specificity for low birthweight and adverse perinatal outcome were evaluated. RESULTS: Different combinations of definitions and reference charts identified substantially different proportions of fetuses within our population as having fetal growth restriction, varying from 38% (with Delphi consensus definition, INTERGROWTH-21st biometric standards, and Arduini Doppler reference ranges) to 93% (with Society for Maternal-Fetal Medicine definition and Hadlock biometric standards). None of the different combinations tested appeared effective, with relative risk for birthweight <10th percentile between 1.4 and 2.1. Birthweight <10th percentile was observed most frequently when selection was made with the GROW/Chitty charts, slightly less with the Hadlock standard, and least frequently with the INTERGROWTH-21st standard. Using the Ebbing Doppler reference ranges resulted in a far higher proportion identified as having fetal growth restriction compared with the Arduini Doppler reference ranges, whereas Delphi consensus definition with Ebbing Doppler reference ranges produced similar results to those of the Society for Maternal-Fetal Medicine definition. Application of Delphi consensus definition with Arduini Doppler reference ranges was significantly associated with adverse perinatal outcome, with any biometric standards/charts. The Society for Maternal-Fetal Medicine definition could not accurately detect adverse perinatal outcome irrespective of estimated fetal weight standard/chart used. CONCLUSION: Different combinations of fetal growth restriction definitions, biometry standards/charts, and Doppler reference ranges identify different proportions of fetuses with fetal growth restriction. The difference in adverse perinatal outcome may be modest, but can have a significant impact in terms of rate of intervention.
引用
- Mylrea-Foley B, Napolitano R, Gordijn S, et al. Do differences in diagnostic criteria for late fetal growth restriction matter? Am J Obstet Gynecol MFM. 2023. PMID: 37544409. doi:10.1016/j.ajogmf.2023.101117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。